NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Gynecology



BMP Sunstone's Propess(R) Recommended as First Line Treatment By the Chinese Medical Association



March 13th, 2008

BMP Sunstone Corporation (NASDAQ:BJGP) (''BMP Sunstone'' or the ''Company''), announced that Propess(R) was recommended by the Obstetrics Group at the Obstetrics and Gynecology Branch of the Chinese Medical Association as the first line treatment for labor induction in late-stage pregnancy.

The Guidelines for Labor Induction in Late-Stage Pregnancy was published in the Chinese Journal of Obstetrics and Gynecology in January 2008. The Guidelines recommended Propess(R) as the first choice for cervical ripening, and further provided details on treatment dosage and agent-delivery.

David Gao, Chief Executive Officer of BMP Sunstone, stated, ''The...


Source: Women's Health Weekly (2008-03-13)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login